Laboratorio Farmaceutico Erfo 1H26 revenue up 1% to EUR 5.05 million, EBIT EUR 771,101
Erfo reported 1H26 revenue of EUR 5.05 million (+1% vs 1H25) and EBIT up 4% to EUR 771,101; medical division revenue rose to EUR 337,000, while Fit and Go contributed EUR 1.1 million. Net financial position improved to EUR 93,828 from EUR 328,579 at Dec. 31, 2025.